IKT 株価推移チャート
IKT 株価予測
Inhibikase Therapeutics Inc
$1.88
-0.31%
$0
本日現在の状況：Apr 28, 10:33:25 GMT-4
戻る
Inhibikase Therapeutics Inc (IKT) 株価予測
主要データ
前終値
$1.89
始値
$1.89
当日レンジ
$1.86 - $1.9
52週レンジ
$1.33 - $2.36
取引高
59.1K
平均取引高
1.5M
配当利回り
--
1株当たり利益(TTM)
-1.15
時価総額
$248.7M
IKTとは何ですか？
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).